Characterization of the heterogeneity in SARS-CoV-2 fitness dynamics via graph representation learning
Zengmiao Wang, Ziqin Zhou, Junfu Wang, Lingyue Yang, Zhirui Zhang, Weina Xu, Zeming Liu, Yuxi Ge, Liang Yang, Xiaoli Wang, Peng Yang, Quanyi Wang, Yunlong Cao, Yuanfang Guo, Huaiyu Tian

TL;DR
The paper introduces Geno-GNN, a deep learning tool that helps understand how SARS-CoV-2 adapts to immunity by predicting its ability to infect cells and evade the immune system.
Contribution
Geno-GNN is a novel graph-based deep learning framework that accurately predicts ACE2 binding and immune escape of SARS-CoV-2.
Findings
SARS-CoV-2 variants predominantly maintain ACE2 binding while achieving moderate immune evasion.
Two distinct fitness trajectories were identified: immune evasion at the cost of infectivity or balanced evasion with maintained infectivity.
Geno-GNN reveals complex evolutionary patterns of SARS-CoV-2 driven by population immunity contexts.
Abstract
Understanding the heterogeneity of population-level viral fitness dynamics, which reflect the interplay between intrinsic viral properties and population immunity, is critical for pandemic preparedness. However, how these dynamics vary across diverse immune backgrounds and mutational landscapes remain poorly characterized. We present Geno-GNN, a graph representation learning approach for retrospectively characterizing the viral fitness dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Geno-GNN accurately predicts angiotensin-converting enzyme 2 (ACE2) binding affinity and immune escape potential across multiple external datasets. Using Geno-GNN, we identified temporal patterns in SARS-CoV-2 fitness and detected varying rates of fitness change associated with distinct immune backgrounds. Virtual mutation scanning revealed two fitness trajectories: broad immune…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11
Figure 12
Figure 13
Figure 14
Figure 15
Figure 16
Figure 17
Figure 18
Figure 19
Figure 20
Figure 21
Figure 22
Figure 23
Figure 24
Figure 25
Figure 26
Figure 27
Figure 28
Figure 29
Figure 30
Figure 31
Figure 32
Figure 33
Figure 34
Figure 35
Figure 36
Figure 37Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
Topicsvaccines and immunoinformatics approaches · SARS-CoV-2 and COVID-19 Research · interferon and immune responses
